Carcinoma in situ i mammae

Marica Skaar; Linnea Langhans; Birgitte Mertz; Niels Kroman

Carcinoma in situ i mammae

Marica Skaar, Linnea Langhans, Birgitte Mertz, Niels Kroman

Institut for Klinisk Medicin

Abstract

Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

Bidragets oversatte titel	Ductal carcinoma in situ
Originalsprog	Dansk
Artikelnummer	V01170084
Tidsskrift	Ugeskrift for Laeger
Vol/bind	180
Udgave nummer	38
Antal sider	4
ISSN	0041-5782
Status	Udgivet - 2018

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

http://ugeskriftet.dk/videnskab/carcinoma-situ-i-mammae

Citationsformater

@article{8294106152d74af0a22612a47bb108e9,

title = "Carcinoma in situ i mammae",

abstract = "Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.",

author = "Marica Skaar and Linnea Langhans and Birgitte Mertz and Niels Kroman",

year = "2018",

language = "Dansk",

volume = "180",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "38",

}

TY - JOUR

T1 - Carcinoma in situ i mammae

AU - Skaar, Marica

AU - Langhans, Linnea

AU - Mertz, Birgitte

AU - Kroman, Niels

PY - 2018

Y1 - 2018

N2 - Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

AB - Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

M3 - Tidsskriftartikel

C2 - 30259839

SN - 0041-5782

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 38

M1 - V01170084

ER -

Carcinoma in situ i mammae

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater